Abstract
Abstract Achieving diversity in clinical trials that reflects the epidemiology of the people and populations affected by diseases and conditions requires an integrated multi-pronged, multi-sector approach and one that is community-informed. This includes among other components community outreach and engagement, patient voice in study design, a culturally competent workforce of clinical trial investigators and team members who are committed to serving URM, and locating clinical trial sites in heavily diverse communities. Bristol Myers Squibb is taking steps and the Bristol Myers Squibb Foundation is making important philanthropic investments on these fronts to drive diversity in clinical trials. The presentation will provide an overview of these efforts, their specific interventions and lessons learned. Citation Format: Patricia M. Doykos. A multi-pronged approach to driving diversity in clinical trials: Bristol Myers Squibb & Bristol Myers Squibb Foundation efforts [abstract]. In: Proceedings of the AACR Virtual Conference: 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2021 Oct 6-8. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2022;31(1 Suppl):Abstract nr IA-53.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
